EUVIMEDEUVIMED entdecken
Crossref

Xinqingning tablet attenuates ischemic stroke complicated by gut dysbiosis through regulating the miR-126–driven gut–brain axis

Shuaishuai Gong, Yuanhao Xu, Ruihao Zhao, Junhe Yu, Liangying Bao, Yuanyuan Zhang, Fang Li, Lei Jiao, Junping Kou

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Shuaishuai Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese…. Hauptthemen laut MEDLINE: MicroRNAs, Drugs, Chinese Herbal, Ischemic Stroke, Dysbiosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ischemic stroke (IS), the predominant clinical stroke subtype, is increasingly linked to dysregulation of the gut-brain axis (GBA)-a bidirectional neuroendocrine-immune interface connecting intestinal homeostasis with cerebrovascular pathophysiology. Xinqingning Tablet (XQNT) demonstrates neuroprotective potential in IS complicated by gut dysbiosis (GD), yet its mechanisms of GBA modulation remain unclear. METHODS: A dual-hit IS-GD mouse model was established via fecal slurry transplantation and permanent middle cerebral artery occlusion (pMCAO) surgery. Gut function was evaluated by constipation indices and histopathological changes, while the neuroprotective efficacy of XQNT (0.36, 0.48, and 0.61 g kg⁻¹) was assessed via TTC staining, neurological deficit scores, cerebral water content, and Evans blue (EB) extravasation assays. Additionally, Western blot was employed to quantify blood-brain barrier (BBB) and inflammation-associated proteins. microRNA sequencing was used to screen the differentially expressed miRNAs. miR-126 expression levels were measured by RT-qPCR, while concentrations of LPS, IL-6 and IL-10 were determined by ELISA. Finally, mechanistic validation employed intravenous miR-126 agonism/antagonism coupled with phenotypic rescue experiments. RESULTS: XQNT conferred robust survival benefits, while concurrently ameliorating intestinal dysfunction and neurovascular injury. Mechanistically, XQNT elevated miR-126 expression, suppressing NF-κB-driven neuroinflammation. Additionally, miR-126 agonism phenocopied XQNT efficacy, whereas miR-126 inhibition abrogated therapeutic benefits. CONCLUSIONS: This study provides early evidence that XQNT functions as a dual-target GBA modulator that alleviates IS with GD via regulation of the miR-126/NF-κB axis. By simultaneously promoting barrier restoration and inflammatory resolution, XQNT offers a promising therapeutic approach that links regulation of the gastrointestinal system with cerebrovascular protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrugs, Chinese HerbalIschemic StrokeDysbiosisNeuroprotective AgentsBrain-Gut AxisAnimalsMaleMiceMice, Inbred C57BLBlood-Brain BarrierBrainNF-kappa BGastrointestinal MicrobiomeDisease Models, AnimalTablets

Stichwörter der Autor:innen

Gut dysbiosisGut–brain axisInflammatory responseIschemic strokeXinqingning tabletmiR-126

Substanzen

MicroRNAsDrugs, Chinese HerbalNeuroprotective AgentsMIRN126 microRNA, mouseNF-kappa BTablets

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Material Medica, School of Traditional Chinese Pharmacy, China Pharma…
  • Department of Neurosurgery, Nanjing Lishui People's Hospital, Nanjing, 211200, China. Electronic address: jlsu2008@126.com.

Förderung

  • National Natural Science Foundation of China
  • China Pharmaceutical University

Zitieren

APA

Gong, S., Xu, Y., Zhao, R., Yu, J., Bao, L., Zhang, Y., Li, F., Jiao, L., & Kou, J. (2025). Xinqingning tablet attenuates ischemic stroke complicated by gut dysbiosis through regulating the miR-126–driven gut–brain axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157356

Vancouver

Gong S, Xu Y, Zhao R, Yu J, Bao L, Zhang Y, et al. Xinqingning tablet attenuates ischemic stroke complicated by gut dysbiosis through regulating the miR-126–driven gut–brain axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157356

BibTeX
@article{Gong2025,
  author = {Gong, Shuaishuai and Xu, Yuanhao and Zhao, Ruihao and Yu, Junhe and Bao, Liangying and Zhang, Yuanyuan and Li, Fang and Jiao, Lei and Kou, Junping},
  title = {Xinqingning tablet attenuates ischemic stroke complicated by gut dysbiosis through regulating the miR-126–driven gut–brain axis},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157356}
}
Kostenlos starten →